Post by Lumanity

Life sciences innovation is moving fast, but the bar for success is higher than ever. John Westwood, SVP, Strategy Consulting argues that value isn’t created by hitting the next clinical milestone alone. Leaders need to shape assets early around a crisp value proposition, fit-for-purpose evidence, and a clear commercialization/partnering path, grounded in patient need, payer expectations, and regulatory realities. How are you building more disciplined go/no-go moments into your development and portfolio process? Learn more: